Cytotopic (Cyto-) IL-15 as a New Immunotherapy for Prostate Cancer: Recombinant Production in <i>Escherichia coli</i> and Purification.

Front Mol Biosci · 2021 · PMC8578882 · PMID 34778376

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The EC50 of mod IL-15 Gen was slightly higher than that of mod IL-15, but this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.